Answers are grounded in this paper and cite their sources.
In the present study, we employed untargeted metabolomics to investigate the synergistic killing mechanism of polymyxin B in combination with an aminoglycoside, amikacin, against a polymyxin-susceptible isolate of Pseudomonas aeruginosa , FADDI-PA111 (MIC = 2 mg/liter for both polymyxin B and amikacin), and a polymyxin-resistant Liverpool epidemic strain (LES), LESB58 (the corresponding MIC for both polymyxin B and amikacin is 16 mg/liter).
No takes yet. Share an insight, caveat, or question.
Hussein et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: